News & Updates
Filter by Specialty:
Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
05 Nov 2021
byAudrey Abella
Use of the oral antiandrogen chlormadinone at a low dose led to improvements in persistence rate of active surveillance (AS), PSA* and testosterone levels and prostate volume, and quality of life (QoL) in men with low-risk prostate cancer (PCa), the PROSAS study has shown.
Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
05 Nov 2021
Weight, OGTT values predict need for insulin therapy among women with GDM
05 Nov 2021
Pregnant women with gestational diabetes mellitus (GDM) who are overweight and have increased blood glucose, as measured by the Oral Glucose Tolerance Test (OGTT), are highly likely to require subsequent insulin therapy, according to a study.
